BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20668813)

  • 1. [Porphyria cutanea tarda, hemosiderosis and hepatocellular carcinoma: report of one case].
    Whittle C; Hepp J; Armas R; Schultz M
    Rev Med Chil; 2010 May; 138(5):581-5. PubMed ID: 20668813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An unhappy triad: hemochromatosis, porphyria cutanea tarda and hepatocellular carcinoma-a case report.
    Mogl MT; Pascher A; Presser SJ; Schwabe M; Neuhaus P; Nuessler NC
    World J Gastroenterol; 2007 Apr; 13(13):1998-2001. PubMed ID: 17461505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of cirrhosis and hepatocellular carcinoma with porphyria cutanea tarda].
    Ishibashi H; Matsunaga T; Dohmen K
    Nihon Rinsho; 1995 Jun; 53(6):1474-8. PubMed ID: 7616664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatocellular carcinoma associated to porphyria cutanea tarda and hepatitis C virus infection without cirrhosis].
    Moreno FJ; Santoyo J; Bondía JA; Suárez MA; Jiménez M; Fernández JL; Conde M; Marín R; Ribeiro M; Peláez JM; de la Fuente A
    Rev Esp Enferm Dig; 1998 Jan; 90(1):48-50. PubMed ID: 9558946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Porphyria cutanea tarda, hepatocarcinoma and hepatitis C virus infection].
    Rodríguez Cuartero A; González Martínez F; Ceballos Torres A
    An Med Interna; 1995 Oct; 12(10):517-8. PubMed ID: 8519952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Porphyria cutanea tarda, chronic liver disease caused by the C virus and hepatocarcinoma. Clinical case].
    Armas R; Krause P; Wolff C
    Rev Med Chil; 1994 Jan; 122(1):72-4. PubMed ID: 7915041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The porphyrias and hepatocellular carcinoma.
    Lim HW; Mascaro JM
    Dermatol Clin; 1995 Jan; 13(1):135-42. PubMed ID: 7712639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma risk in patients with porphyria cutanea tarda.
    Gisbert JP; García-Buey L; Alonso A; Rubio S; Hernández A; Pajares JM; García-Díez A; Moreno-Otero R
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):689-92. PubMed ID: 15201583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyria cutanea tarda: Recent update.
    Singal AK
    Mol Genet Metab; 2019 Nov; 128(3):271-281. PubMed ID: 30683557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C virus infection in a patient with porphyria cutanea tarda and hepatocarcinoma].
    Sancho MT; Martín JC; García J; Sierra FJ; Lavilla P; Gil Aguado A
    Rev Clin Esp; 1996 Oct; 196(10):725-6. PubMed ID: 9005481
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytoplasmic liver cell inclusions--a typical feature of porphyria cutanea tarda--are absent in porphyria-related hepatic neoplasias.
    Fakan F; Chlumská A; Krijt J; Kocová L
    Neoplasma; 1998; 45(2):102-6. PubMed ID: 9687891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical findings in porphyria cutanea tarda].
    Heilmann E; Vakilzadeh F
    Fortschr Med; 1977 Mar; 95(10):659-61. PubMed ID: 844765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyria cutanea tarda increases risk of hepatocellular carcinoma and premature death: a nationwide cohort study.
    Baravelli CM; Sandberg S; Aarsand AK; Tollånes MC
    Orphanet J Rare Dis; 2019 Apr; 14(1):77. PubMed ID: 30944007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum iron and copper and their relations to hepatocellular carcinoma in porphyria cutanea tarda and hemochromatosis patients--case report.
    Dabrowska E; Jabłońska-Kaszewska I; Lukasiak J; Dorosz A; Falkiewicz B
    Biofactors; 2000; 11(1-2):131-4. PubMed ID: 10705984
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver cirrhosis and chronic hepatic porphyria].
    Pätzold K; Hahn L; Lohmann J; Porst H
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():114-5. PubMed ID: 7483690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyria cutanea tarda induced by tamoxifen.
    Cruz MJ; Alves S; Baudrier T; Azevedo F
    Dermatol Online J; 2010 Sep; 16(9):2. PubMed ID: 20875323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long-term follow-up.
    Kordac V
    Neoplasma; 1972; 19(2):135-9. PubMed ID: 4336890
    [No Abstract]   [Full Text] [Related]  

  • 20. [Echographic detection of hepatocellular carcinoma in patients hospitalized for cirrhosis].
    Roget L; Coppéré H; Richard P; Barthélém C; Veyret C; Audigier JC
    Gastroenterol Clin Biol; 1988 Nov; 12(11):827-32. PubMed ID: 2464520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.